DNA methylation of the BMAL1 promoter

Biochemical and Biophysical Research Communications

Volumn 440, Issue 3, 2013, Pages 449-453

  Satou, R ^a   Sugihara, N ^a   Ishizuka, Y ^a   Matsukubo, T ^a   Onishi, Y ^b  

^a TOKYO DENTAL COLLEGE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Circadian rhythm; Clock genes; Hematological malignancy; Transcription

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CRYPTOCHROME 1; PER2 PROTEIN; PROTEIN BMAL1;

ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; OSCILLATION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

MAMMALIA;

CIRCADIAN RHYTHM; CLOCK GENES; HEMATOLOGICAL MALIGNANCY; TRANSCRIPTION;

ARNTL TRANSCRIPTION FACTORS; AZACITIDINE; CELL LINE; CIRCADIAN RHYTHM; CPG ISLANDS; CRYPTOCHROMES; DNA METHYLATION; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; PERIOD CIRCADIAN PROTEINS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

EID: 84888129517     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.09.124     Document Type: Article

References (32)

1. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
2. Bunger M.K., Wilbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., Simon M.C., Takahashi J.S., Bradfield C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
3. Bechtold D.A., Gibbs J.E., Loudon A.S. Circadian dysfunction in disease. Trends Pharmacol. Sci. 2010, 31:191-198.
4. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
5. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 2006, 31:89-97.
6. Liu H.C., Hu C.J., Tang Y.C., Chang J.G. A pilot study for circadian gene disturbance in dementia patients. Neurosci. Lett. 2008, 435:229-233.
7. Lin Q., Ding H., Zheng Z., Gu Z., Ma J., Chen L., Chan P., Cai Y. Promoter methylation analysis of seven clock genes in Parkinson's disease. Neurosci. Lett. 2012, 507:147-150.
8. Hoffman A.E., Yi C.H., Zheng T., Stevens R.G., Leaderer D., Zhang Y., Holford T.R., Hansen J., Paulson J., Zhu Y. CLOCK in breast tumorigenesis: genetic, epigenetic and transcriptional profiling analyses. Cancer Res. 2010, 70:1459-1468.
9. Chen S.T., Choo K.B., Hou M.F., Yeh K.T., Kuo S.J., Chang J.G. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005, 26:1241-1246.
10. Yang M.Y., Chang J.G., Lin P.M., Tang K.P., Chen Y.H., Lin H.Y., Liu T.C., Hsiao H.H., Liu Y.C., Lin S.F. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006, 97:1298-1307.
11. Hsu M.C., Huang C.C., Choo K.B., Huang C.J. Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells. Biochem. Biophys. Res. Commun. 2007, 360:257-262.
12. Gery S., Komatsu N., Kawamata N., Miller C.W., Desmond J., Virk R.K., Marchevsky A., Mckenna R., Taguchi H., Koeffler H.P. Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin. Cancer Res. 2007, 13:1399-1404.
13. Taniguchi H., Fernandez A.F., Setien F., Ropero S., Ballestar E., Villanueva A., Yamamoto H., Imai K., Shinomura Y., Esteller M. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009, 69:8447-8454.
14. Ueda H.R., Chen W., Adachi A., Wakamatsu H., Hayashi S., Takasugi T., Nagano M., Nakahama K., Suzuki Y., Sugano S., Iino M., Shigeyoshi Y., Hashimoto S. A transcription factor response element for gene expression during circadian night. Nature 2002, 418:534-539.
15. Onishi Y., Hanai S., Ohno T., Hara Y., Ishida N. Rhythmic SAF-A binding underlies circadian transcription of the BMAL1 gene. Mol. Cell. Biol. 2008, 28:3477-3488.
16. Onishi Y. HSG cells, a model in the submandibular clock. Biosci. Rep. 2010, 31:57-62.
17. Onishi Y., Kawano Y. Rhythmic binding of topoisomerase I impacts on the transcription of BMAL1 and circadian period. Nucleic Acids Res. 2012, 40:9482-9492.
18. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
19. Ohno T., Onishi Y., Ishida N. The negative transcription factor E4BP4 is associated with circadian clock protein PERIOD2. Biochem. Biophys. Res. Commun. 2007, 354:1010-1015.
20. Onishi Y., Wada-Kiyama Y., Kiyama R. Expression-dependent perturbation of nucleosomal phases at HS2 of the human β-LCR: possible correlation with periodic bent DNA. J. Mol. Biol. 1998, 284:989-1004.
21. Onishi Y., Oishi K., Kawano Y., Yamazaki Y. The harmala alkaloid, harmine is a modulator of circadian BMAL1 transcription. Biosci. Rep. 2011, 32:45-52.
22. Lee C.C. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006, 17:525-530.
23. Yu W., Nomura M., Ikeda M. Interactivating feedback loops within the mammalian clock: BMAL1 is negatively autoregulated and upregulated by CRY1, CRY2, and PER2. Biochem. Biophys. Res. Commun. 2002, 290:933-941.
24. Onishi Y., Kawano Y., Yamazaki Y. Lycorine, a candidate for the control of period length in mammalian cells. Cell. Physiol. Biochem. 2012, 29:407-416.
25. Andoh T., Ishii K., Suzuki Y., Ikegami Y., Kusunoki Y., Takemoto Y., Okada K. Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc. Natl. Acad. Sci. USA 1987, 84:5565-5569.
26. Bunger M.K., Wilsbacher L.D., Moran S.M., Clendenin C., Radcliffe L.A., Hogenesch J.B., Simon M.C., Takahashi J.S., Bradfield C.A. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 2000, 103:1009-1017.
27. McDearmon E.L., Patel K.L., Ko C.H., Walisser J.A., Schook A.C., Chong J.L., Wilsbacher L.D., Song E.J., Hong H.-K., Bradfield C.A., Takahashi J.S. Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science 2006, 314:1304-1308.
28. Hanoun M., Eisele L., Suzuki M., Greally J.M., Huttmann A., Aydin S., Scholtysik R., Klein-Hitpass L., Duhrsen U., Durig J. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS One 2012, 7:e34347.
29. Lee Y., Chen R., Lee H.M., Lee C. Stoichiometric relationship among clock proteins determines robustness of circadian rhythms. J. Biol. Chem. 2011, 286:7033-7042.
30. Chung S., Son G.H., Kim K. Circadian rhythm of adrenal glucocorticoid: its regulation and clinical implications. Biochim. Biophys. Acta 1812, 2011:581-591.
31. Milagro F.I., Gomez-Abellan P., Campion J., Martinez J.A., Ordovas J.M., Garaulet M. CLOCK, PER2 and BMAL1 DNA methylation: association with obesity and metabolic syndrome characteristics and monounsaturated fat intake. Chronobiol. Int. 2012, 29:1180-1194.
32. Ji Y., Qin Y., Shu H., Li X. Methylation analyses on promoters of mPer1, mPer2, and mCry1 during perinatal development. Biochem. Biophys. Res. Commun. 2010, 391:1742-1747.